The Lancet Neurology in conversation with

Beau Ances on amyloid biomarkers in Alzheimer’s

The Lancet Neurology

Beau Ances (Washington University in St Louis, MO, USA) discusses recent research on amyloid biomarkers in people with genetic forms of Alzheimer’s disease; his Article is published in the January issue of The Lancet Neurology.

Read the full article:
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv